Wolverine Asset Management’s Genetic Technologies Ltd. GENE Stock Holding History

Wolverine Asset Management’s Portfolio GENE Stock Details GENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-7,540	Closed	-$268K	–	1979
2015 Q3	$268K	Sell	7,540 -10	-0.1%	-$536	0.01%	842
2015 Q2	$459K	Buy	7,550 +900	+14%	+$75.4K	0.01%	669
2015 Q1	$700K	Buy	+6,650	New	+$544K	0.01%	532

Other funds holding GENE

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

AIA

Allegis Investment Advisors Idaho Falls, Idaho $326M AUM 10.36% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Wolverine Asset Management's GENE Position: Q4 2015 in Review

Wolverine Asset Management sold out of Genetic Technologies Ltd. (GENE) in Q4 2015, closing a stake of 7,540 shares — an estimated $268K sold.

Wolverine Asset Management first reported a position in GENE in Q1 2015 and held it in 3 quarters. The position peaked at $700K in Q1 2015. 11 funds tracked by Wall St. Rank hold GENE as of Q4 2015.

Wolverine Asset Management reported no remaining Genetic Technologies Ltd. position as of Q4 2015 after selling out during the quarter.
Wolverine Asset Management sold 7,540 Genetic Technologies Ltd. shares in Q4 2015, an estimated $268K.
Wolverine Asset Management first reported a position in Genetic Technologies Ltd. in Q1 2015 and held it in 3 quarters.
Wolverine Asset Management's Genetic Technologies Ltd. position peaked at $700K in Q1 2015.
11 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q4 2015.

Based on Wolverine Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.